Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue plasminogen activator and plasmin independently decrease human neutrophil activation.

J L Mehta1, P Mehta, D L Lawson

  • 1Department of Medicine, College of Medicine, University of Florida, Gainesville.

Life Sciences
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease.

Vascular pharmacology·2023
Same author

Does aspirin save lives in patients with COVID-19?

Heart (British Cardiac Society)·2021
Same author

Atrial fibrillation following autologous stem cell transplantation in patients with multiple myeloma: incidence and risk factors.

Therapeutic advances in cardiovascular disease·2012
Same author

LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouse.

Gene therapy·2011
Same author

Systemic human Netrin-1 gene delivery by adeno-associated virus type 8 alters leukocyte accumulation and atherogenesis in vivo.

Gene therapy·2010
Same author

Statins and altered glucose metabolism: a laboratory curiosity or a new disease?

Journal of the American College of Cardiology·2010
Same journal

Steroidal alkaloid H89712 ameliorates neuroinflammation and memory deficits: Enhancing cerebral oxidative phosphorylation in APP/PS1 mice.

Life sciences·2026
Same journal

Targeting PARP1-dependent parthanatos in Alzheimer's disease: Mechanisms and therapeutic opportunities.

Life sciences·2026
Same journal

The emerging role of NAT10-mediated N4-acetylcytidine modification of RNA in bone diseases: Current frontiers and future challenges.

Life sciences·2026
Same journal

Overactivated bradykinin-B2 receptor promotes type a aortic dissection by inducing endothelial dysfunction: Therapeutic effect of icatibant.

Life sciences·2026
Same journal

Gut microbiota and metabolites in remodeling the tumor microenvironment and regulating immunotherapeutic efficacy in colorectal cancer.

Life sciences·2026
Same journal

A CD31-derived cytoplasmic ITIM peptide enhances epidermal and dermal regeneration in cutaneous wound repair.

Life sciences·2026
See all related articles

Tissue-plasminogen activator (t-PA) and plasmin inhibit neutrophil functions. t-PA

Area of Science:

  • Biochemistry
  • Immunology
  • Hematology

Background:

  • Tissue-plasminogen activator (t-PA) and plasmin reduce platelet aggregation, aiding thrombolysis.
  • Neutrophils are implicated in reperfusion injury.
  • Understanding t-PA and plasmin effects on neutrophils is crucial for thrombotic disorder treatment.

Purpose of the Study:

  • To investigate the impact of t-PA and plasmin on human neutrophil function.
  • To differentiate the mechanisms of action between t-PA and plasmin on neutrophils.

Main Methods:

  • Isolated human neutrophils were treated with varying concentrations of t-PA and plasmin.
  • Neutrophil functions assessed included f-MLP-induced chemotaxis and ionophore A23187-induced superoxide and LTB4 release.
  • The role of plasmin generation was evaluated using the plasmin inhibitor epsilon-aminocaproic acid (epsilon-ACA).

Related Experiment Videos

Main Results:

  • Both t-PA and plasmin decreased neutrophil chemotaxis, superoxide release, and LTB4 production.
  • The inhibitory effects of t-PA were independent of plasmin generation, as they were not blocked by epsilon-ACA.
  • The effects of plasmin on neutrophil functions were inhibited by epsilon-ACA, confirming plasmin-dependent action.

Conclusions:

  • Both t-PA and plasmin modulate human neutrophil functions.
  • t-PA exerts its effects independently of plasmin generation.
  • These findings suggest that the combined actions of t-PA and plasmin on neutrophils may influence the overall efficacy of t-PA in managing thrombotic disorders.